ERUSALIMSKY, Jorge Daniel,FRANKLIN, Richard,DAMMENT, Stephen
申请号:
DK15817516
公开号:
DK3236967T3
申请日:
2015.12.22
申请国别(地区):
DK
年份:
2020
代理人:
摘要:
The present invention relates to the use of the anti-megakaryocytic agent anagrelide, or a therapeutically active metabolite thereof, in the prevention or treatment of metastatic disease in cancer patients displaying paraneoplastic thrombocytosis.